A Review on Medicinal Drugs used in Treatment of Diabetics
Abstract
This terrible disease is established in the world of all parts and applies to a significant threat to the health of mankind. Diabetes is a chronic disease of protein metabolism, carbohydrate, and fat, in which fasting and subsequent blood sugar levels rise. Diabetes mellitus is diabetes of complex metabolic that results from insulin dysfunction or insulin insufficiency. The WHO predicts that developing countries will bear a greater burden. The WHO (World Health Organization) has recorded 21,000 plants, utilized for medicinal purposes worldwide. There are several herbal treatments indicated for diabetes complications and diabetes. Research-based validation of plant species in several Indian has shown the efficacy of vegetation in reducing levels of sugar that can be considered of potential therapeutic effect.
How to cite this article: Maurya D, Saraswat N. A Review on Medicinal Drugs used in Treatment of Diabetics. J Durg Dis Dev 2019; 3(2): 1-3.
References
Ramachandran A, Snehalatha C, Viswanathan V et al. Burden of type 2 diabetes and its complications- the Indian scenario. Curr Sci 2002; 83: 1471-1476.
Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care, 2000; 23: 1182-1186.
Seth SD, Sharma B. Medicinal plants of India. Indian J Med Res 2004; 120: 9-11.
Oberlay LW. Free radicals, and diabetes. Free Radic Biol Med 1988; 5: 113-124.
Baynes JW, Thorpe SR. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 1997; 3: 277-284
Manisha M, Priyanjali D, Jayant L et al. Indian Herbs and Herbal Drugs Used for the Treatment of Diabetes., J Clin Biochem Nutr 2007; 40: 163-173.
Kaleem M, Asif M, Ahmed QU et al. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med. J 2006; 47: 670-675.
Gupta RK, Kesari AN, Murthy P et al. Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals. J Ethnopharmacol 2005; 99: 75–81.
Kumar KCS, Muller K. Medicinal plants from Nepal, II. Evaluation as inhibitors of lipid peroxidation in biological membranes. J Ethnopharmacol 1999; 64: 135-139.
Rajesham VV, Ravindernath A, Bikshapathi DVRN. A review on medicinal plant and herbal drug formulation used I diabetes mellitus, Indo American Journal of Pharmaceutical Research 2012; 2(10).
Basavaraj K. Nanjwade Polyherbal Formulations for Diabetes. 7th September 2011 in 14th Asian Chemical Congress.
Zohreh B , Herbal Medicines in Diabetes. Iranan journal of diabetes and obesity. 2011; 2(3): 1-10.
Karunanayake EH, Welihinda J, Sirimanne SR et al. Oral hypoglycemic activity of some medicinal plants of Sri Lanka. J Ethnopharmacol 1984; 11: 223-231.
Ohadoma SC, Michael HU. Effects of co-administration of methanol leaf extract of Catharanthus roseus on the hypoglycemic activity of metformin and glibenclamide in rats. Asian Pac J Trop Med 2011; 475-477.
Biswas K, Chattopadhyay I, Banerjee RK et al. Biological activities and medicinal properties of neem (Azadiracta indica). Curr Sci 2002; 82: 1336–1345.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.